Items tagged with Drug-resistant TB

Romania: The silent disease (post)

Romania has the highest number of resistant TB patients in Europe.

Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis (post)

Johnson & Johnson announces new grant to Harvard Medical School to combat drug-resistant tuberculosis (post)

New collaboration will help address significant global unmet needs in pediatric drug-resistant tuberculosis (DR-TB) treatment and optimize use of existing DR-TB treatments

MDR-TB deaths in Mumbai less than national average, 350 patients cured (post)

MUMBAI: As many as 1,033 of the 7,483 people diagnosed with drug-resistant tuberculosis in the city have died over the past five years. But with a 14% mortality rate, the city seems to have fared better than the national average of 25%.

Minsk has extremely high levels of drug-resistant TB, a study in Belarus reveals (post)

Resistance to anti-tuberculosis (TB) medicines is a major public health threat in most countries of the former Soviet Union. As no representative and quality-assured information on the magnitude of this problem existed in Belarus, a survey was conducted in the city of Minsk, the capital of Belarus. Between November 2009 and December 2010, 156 consecutively diagnosed new and 68 previously treated culture-positive TB patients residing in Minsk were enrolled in the survey.

Adherence to ART and XDR-TB therapy in Kwa-Zulu Natal province (post)

Adherence to antiretroviral therapy (ART) approached 90% in a 104-person prospective study in KwaZulu-Natal province, South Africa. Adherence to multiple medications for extensively drug-resistant tuberculosis (XDR-TB) was 20% lower.

Global financing and long-term technical assistance for multidrug-resistant tuberculosis: Scaling up access to treatment (post)

Summary Points

New MSF study: Collaborative blogging helps people living with TB (post)

September 23, 2014 - London/Geneva - A study published this week in PLOS ONE by Médecins Sans Frontières/Doctors Without Borders (MSF) highlights the potential for social media to support patients undergoing treatment for multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). The qualitative research examined the experiences of patients and health staff involved in the ‘TB & ME’ collaborative blogging project for patients undergoing treatment for MDR and XDR TB around the world. TB&ME gives MDR-TB patients an opportunity to tell the world about the issues which affect their lives, about how treatment and services could be improved and how it feels to have this disease.

XDR-TB patients smuggle pills as treatment priced out of reach (post)

With treatment priced out of reach, some extensively drug-resistant tuberculosis (XDR-TB) patients face a tough choice: Break the law or die.

New weapons against multidrug resistance in tuberculosis (post)

Using a high-throughput screening assay, EPFL scientists have discovered two small molecules that could overcome the multidrug resistance of the bacterium that causes tuberculosis.